世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

認知症・運動障害治療の世界市場


Global Dementia and Movement Disorder Treatment Market

認知症・運動障害治療の世界市場 2022-2026 年 Technavioは、認知症・運動障害治療市場をモニタリングしており、2022-2026年の間に71億4000万ドルの成長が見込まれ、予測期間中にCAGR6.95%で加速しています。当... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年5月4日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報・注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

認知症・運動障害治療の世界市場 2022-2026 年
Technavioは、認知症・運動障害治療市場をモニタリングしており、2022-2026年の間に71億4000万ドルの成長が見込まれ、予測期間中にCAGR6.95%で加速しています。当レポートでは、認知症と運動障害の治療市場について、市場規模や予測、トレンド、成長ドライバー、課題、約25のベンダーを網羅したベンダー分析など、包括的な分析を提供しています。
また、現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境についての最新分析も行っています。市場は、老年人口の増加、対象疾患の有病率の上昇、国民の意識を高める戦略の出現によって牽引されています。
認知症および運動障害治療市場の分析には、クラス別セグメントと地理的展望が含まれます。
Technavioの認知症および運動障害治療市場は、以下のように区分されています。
薬物クラス別
- MAO阻害剤
- アセチルコリンエステラーゼ阻害剤
- グルタミン酸阻害剤
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における認知症・運動障害治療市場の成長を促進する主な理由の1つとして、バイオマーカーの出現を挙げています。また、アルツハイマー病に関連する認知機能低下を逆転させるための遺伝子治療の成長と生物医学の進歩は、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細なイメージを提示します。認知症と運動障害の治療市場に関する当レポートは、以下の分野を対象としています。
- 認知症および運動障害治療市場のサイジング
- 認知症および運動障害治療市場の予測
- 認知症および運動障害治療市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Acorda Therapeutics Inc.、Amneal Pharmaceuticals Inc.、Bausch Health Companies Inc.、Biogen Inc、Eisai Co.Ltd.、グラクソ・スミスクラインPlc、H Lundbeck AS、ジョンソン・アンド・ジョンソン、協和キリンCo.Ltd.、Lannett Co. Inc.、Merck and Co.Inc.、ニューロクライン・バイオサイエンシズ社、ノバルティス社、オルガノン社、オリオンファーマ社、大塚ホールディングス社、日本ケミコン社、日本ケミコン社、日本ケミコン社、日本ケミコン社、日本ケミコン社、日本ケミコン社、日本ケミコン社Ltd.、Supernus Pharmaceuticals Inc.、Teva Pharmaceutical Industries Ltd.、UCB SA、Vertical Pharmaceuticals LLCの7社です。また、認知症・運動障害治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/dementia-and-movement-disorder-treatment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Drug Class
o 5.1 Market segments
o Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
o 5.2 Comparison by Drug Class
o Exhibit 26: Chart on Comparison by Drug Class
o Exhibit 27: Data Table on Comparison by Drug Class
o 5.3 MAO inhibitors - Market size and forecast 2021-2026
o Exhibit 28: Chart on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on MAO inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on MAO inhibitors - Year-over-year growth 2021-2026 (%)
o 5.4 Acetylcholinesterase inhibitors - Market size and forecast 2021-2026
o Exhibit 32: Chart on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
o 5.5 Glutamate inhibitors - Market size and forecast 2021-2026
o Exhibit 36: Chart on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Drug Class
o Exhibit 44: Market opportunity by Drug Class ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 93: AbbVie Inc. - Overview
o Exhibit 94: AbbVie Inc. - Product / Service
o Exhibit 95: AbbVie Inc. - Key offerings
o 10.4 Biogen Inc.
o Exhibit 96: Biogen Inc. - Overview
o Exhibit 97: Biogen Inc. - Product / Service
o Exhibit 98: Biogen Inc. - Key offerings
o 10.5 Eisai Co. Ltd.
o Exhibit 99: Eisai Co. Ltd. - Overview
o Exhibit 100: Eisai Co. Ltd. - Business segments
o Exhibit 101: Eisai Co. Ltd. - Key offerings
o Exhibit 102: Eisai Co. Ltd. - Segment focus
o 10.6 H Lundbeck AS
o Exhibit 103: H Lundbeck AS - Overview
o Exhibit 104: H Lundbeck AS - Product / Service
o Exhibit 105: H Lundbeck AS - Key offerings
o 10.7 Johnson and Johnson
o Exhibit 106: Johnson and Johnson - Overview
o Exhibit 107: Johnson and Johnson - Business segments
o Exhibit 108: Johnson and Johnson - Key news
o Exhibit 109: Johnson and Johnson - Key offerings
o Exhibit 110: Johnson and Johnson - Segment focus
o 10.8 Merck and Co. Inc.
o Exhibit 111: Merck and Co. Inc. - Overview
o Exhibit 112: Merck and Co. Inc. - Business segments
o Exhibit 113: Merck and Co. Inc. - Key news
o Exhibit 114: Merck and Co. Inc. - Key offerings
o Exhibit 115: Merck and Co. Inc. - Segment focus
o 10.9 Novartis AG
o Exhibit 116: Novartis AG - Overview
o Exhibit 117: Novartis AG - Business segments
o Exhibit 118: Novartis AG - Key offerings
o Exhibit 119: Novartis AG - Segment focus
o 10.10 Otsuka Holdings Co. Ltd.
o Exhibit 120: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 121: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 122: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 123: Otsuka Holdings Co. Ltd. - Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 126: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 UCB SA
o Exhibit 129: UCB SA - Overview
o Exhibit 130: UCB SA - Product / Service
o Exhibit 131: UCB SA - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 132: Inclusions checklist
o Exhibit 133: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 134: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 135: Research methodology
o Exhibit 136: Validation techniques employed for market sizing
o Exhibit 137: Information sources
o 11.5 List of abbreviations
o Exhibit 138: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Drug Class ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Biogen Inc. - Overview
Exhibits97: Biogen Inc. - Product / Service
Exhibits98: Biogen Inc. - Key offerings
Exhibits99: Eisai Co. Ltd. - Overview
Exhibits100: Eisai Co. Ltd. - Business segments
Exhibits101: Eisai Co. Ltd. - Key offerings
Exhibits102: Eisai Co. Ltd. - Segment focus
Exhibits103: H Lundbeck AS - Overview
Exhibits104: H Lundbeck AS - Product / Service
Exhibits105: H Lundbeck AS - Key offerings
Exhibits106: Johnson and Johnson - Overview
Exhibits107: Johnson and Johnson - Business segments
Exhibits108: Johnson and Johnson - Key news
Exhibits109: Johnson and Johnson - Key offerings
Exhibits110: Johnson and Johnson - Segment focus
Exhibits111: Merck and Co. Inc. - Overview
Exhibits112: Merck and Co. Inc. - Business segments
Exhibits113: Merck and Co. Inc. - Key news
Exhibits114: Merck and Co. Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Segment focus
Exhibits116: Novartis AG - Overview
Exhibits117: Novartis AG - Business segments
Exhibits118: Novartis AG - Key offerings
Exhibits119: Novartis AG - Segment focus
Exhibits120: Otsuka Holdings Co. Ltd. - Overview
Exhibits121: Otsuka Holdings Co. Ltd. - Business segments
Exhibits122: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits123: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits124: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits125: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits126: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits127: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits128: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits129: UCB SA - Overview
Exhibits130: UCB SA - Product / Service
Exhibits131: UCB SA - Key offerings
Exhibits132: Inclusions checklist
Exhibits133: Exclusions checklist
Exhibits134: Currency conversion rates for US$
Exhibits135: Research methodology
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Information sources
Exhibits138: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Dementia And Movement Disorder Treatment Market 2022-2026
Technavio has been monitoring dementia and movement disorder treatment market and it is poised to grow by $ 7.14 bn during 2022-2026, accelerating at a CAGR of 6.95% during the forecast period. Our report on the dementia and movement disorder treatment market provides a holistic analysis, of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, the rising prevalence of target diseases, and the emergence of strategies to increase public awareness.
Dementia and movement disorder treatment market analysis include class segment and geographic landscape.
Technavio's dementia and movement disorder treatment market is segmented as below:
By Drug Class
• MAO inhibitors
• Acetylcholinesterase inhibitors
• Glutamate inhibitors
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the emergence of biomarkers as one of the prime reasons driving dementia and movement disorder treatment market growth during the next few years. Also, the growth of gene therapy to reverse cognitive decline associated with Alzheimer's disease and advances in biomedical science will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the dementia and movement disorder treatment market covers the following areas:
• Dementia and movement disorder treatment market sizing
• Dementia and movement disorder treatment market forecast
• Dementia and movement disorder treatment market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dementia and movement disorder treatment market vendors that include AbbVie Inc., Acorda Therapeutics Inc., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Biogen Inc., Eisai Co. Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Johnson and Johnson, Kyowa Kirin Co. Ltd., Lannett Co. Inc., Merck and Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Organon and Co., Orion Pharma Ltd., Otsuka Holdings Co. Ltd., Supernus Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., UCB SA, and Vertical Pharmaceuticals LLC. Also, dementia and movement disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/dementia-and-movement-disorder-treatment-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Drug Class
o 5.1 Market segments
o Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
o 5.2 Comparison by Drug Class
o Exhibit 26: Chart on Comparison by Drug Class
o Exhibit 27: Data Table on Comparison by Drug Class
o 5.3 MAO inhibitors - Market size and forecast 2021-2026
o Exhibit 28: Chart on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on MAO inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on MAO inhibitors - Year-over-year growth 2021-2026 (%)
o 5.4 Acetylcholinesterase inhibitors - Market size and forecast 2021-2026
o Exhibit 32: Chart on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
o 5.5 Glutamate inhibitors - Market size and forecast 2021-2026
o Exhibit 36: Chart on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Drug Class
o Exhibit 44: Market opportunity by Drug Class ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 93: AbbVie Inc. - Overview
o Exhibit 94: AbbVie Inc. - Product / Service
o Exhibit 95: AbbVie Inc. - Key offerings
o 10.4 Biogen Inc.
o Exhibit 96: Biogen Inc. - Overview
o Exhibit 97: Biogen Inc. - Product / Service
o Exhibit 98: Biogen Inc. - Key offerings
o 10.5 Eisai Co. Ltd.
o Exhibit 99: Eisai Co. Ltd. - Overview
o Exhibit 100: Eisai Co. Ltd. - Business segments
o Exhibit 101: Eisai Co. Ltd. - Key offerings
o Exhibit 102: Eisai Co. Ltd. - Segment focus
o 10.6 H Lundbeck AS
o Exhibit 103: H Lundbeck AS - Overview
o Exhibit 104: H Lundbeck AS - Product / Service
o Exhibit 105: H Lundbeck AS - Key offerings
o 10.7 Johnson and Johnson
o Exhibit 106: Johnson and Johnson - Overview
o Exhibit 107: Johnson and Johnson - Business segments
o Exhibit 108: Johnson and Johnson - Key news
o Exhibit 109: Johnson and Johnson - Key offerings
o Exhibit 110: Johnson and Johnson - Segment focus
o 10.8 Merck and Co. Inc.
o Exhibit 111: Merck and Co. Inc. - Overview
o Exhibit 112: Merck and Co. Inc. - Business segments
o Exhibit 113: Merck and Co. Inc. - Key news
o Exhibit 114: Merck and Co. Inc. - Key offerings
o Exhibit 115: Merck and Co. Inc. - Segment focus
o 10.9 Novartis AG
o Exhibit 116: Novartis AG - Overview
o Exhibit 117: Novartis AG - Business segments
o Exhibit 118: Novartis AG - Key offerings
o Exhibit 119: Novartis AG - Segment focus
o 10.10 Otsuka Holdings Co. Ltd.
o Exhibit 120: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 121: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 122: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 123: Otsuka Holdings Co. Ltd. - Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 124: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 125: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 126: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 UCB SA
o Exhibit 129: UCB SA - Overview
o Exhibit 130: UCB SA - Product / Service
o Exhibit 131: UCB SA - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 132: Inclusions checklist
o Exhibit 133: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 134: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 135: Research methodology
o Exhibit 136: Validation techniques employed for market sizing
o Exhibit 137: Information sources
o 11.5 List of abbreviations
o Exhibit 138: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on MAO inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on MAO inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Acetylcholinesterase inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Acetylcholinesterase inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Glutamate inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Glutamate inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Drug Class ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Biogen Inc. - Overview
Exhibits97: Biogen Inc. - Product / Service
Exhibits98: Biogen Inc. - Key offerings
Exhibits99: Eisai Co. Ltd. - Overview
Exhibits100: Eisai Co. Ltd. - Business segments
Exhibits101: Eisai Co. Ltd. - Key offerings
Exhibits102: Eisai Co. Ltd. - Segment focus
Exhibits103: H Lundbeck AS - Overview
Exhibits104: H Lundbeck AS - Product / Service
Exhibits105: H Lundbeck AS - Key offerings
Exhibits106: Johnson and Johnson - Overview
Exhibits107: Johnson and Johnson - Business segments
Exhibits108: Johnson and Johnson - Key news
Exhibits109: Johnson and Johnson - Key offerings
Exhibits110: Johnson and Johnson - Segment focus
Exhibits111: Merck and Co. Inc. - Overview
Exhibits112: Merck and Co. Inc. - Business segments
Exhibits113: Merck and Co. Inc. - Key news
Exhibits114: Merck and Co. Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Segment focus
Exhibits116: Novartis AG - Overview
Exhibits117: Novartis AG - Business segments
Exhibits118: Novartis AG - Key offerings
Exhibits119: Novartis AG - Segment focus
Exhibits120: Otsuka Holdings Co. Ltd. - Overview
Exhibits121: Otsuka Holdings Co. Ltd. - Business segments
Exhibits122: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits123: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits124: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits125: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits126: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits127: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits128: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits129: UCB SA - Overview
Exhibits130: UCB SA - Product / Service
Exhibits131: UCB SA - Key offerings
Exhibits132: Inclusions checklist
Exhibits133: Exclusions checklist
Exhibits134: Currency conversion rates for US$
Exhibits135: Research methodology
Exhibits136: Validation techniques employed for market sizing
Exhibits137: Information sources
Exhibits138: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/16 10:26

159.45 円

174.07 円

209.46 円

ページTOPに戻る